Tocqueville Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,150
Closed -$597K 737
2021
Q1
$597K Buy
+23,150
New +$597K 0.01% 521
2020
Q3
Sell
-13,625
Closed -$660K 648
2020
Q2
$660K Hold
13,625
0.01% 445
2020
Q1
$576K Hold
13,625
0.01% 431
2019
Q4
$583K Sell
13,625
-19,900
-59% -$852K 0.01% 528
2019
Q3
$1.21M Sell
33,525
-35,543
-51% -$1.28M 0.02% 437
2019
Q2
$1.85M Sell
69,068
-23,800
-26% -$636K 0.02% 399
2019
Q1
$2.49M Buy
92,868
+41,000
+79% +$1.1M 0.03% 365
2018
Q4
$839K Hold
51,868
0.01% 484
2018
Q3
$1.08M Buy
51,868
+33,168
+177% +$689K 0.01% 491
2018
Q2
$286K Sell
18,700
-14,480
-44% -$221K ﹤0.01% 704
2018
Q1
$746K Buy
33,180
+2,020
+6% +$45.4K 0.01% 549
2017
Q4
$938K Sell
31,160
-14,100
-31% -$424K 0.01% 516
2017
Q3
$1.71M Sell
45,260
-55,300
-55% -$2.08M 0.02% 469
2017
Q2
$2.81M Buy
100,560
+610
+0.6% +$17K 0.03% 376
2017
Q1
$3.44M Buy
99,950
+6,675
+7% +$229K 0.04% 350
2016
Q4
$2.69M Sell
93,275
-31,850
-25% -$919K 0.03% 371
2016
Q3
$3.98M Buy
125,125
+12,725
+11% +$405K 0.05% 324
2016
Q2
$3.65M Buy
112,400
+16,750
+18% +$544K 0.04% 334
2016
Q1
$2.67M Buy
95,650
+41,660
+77% +$1.16M 0.04% 361
2015
Q4
$1.93M Buy
53,990
+1,750
+3% +$62.4K 0.03% 431
2015
Q3
$1.73M Buy
52,240
+1,200
+2% +$39.7K 0.02% 464
2015
Q2
$2.14M Buy
51,040
+100
+0.2% +$4.19K 0.03% 458
2015
Q1
$1.66M Buy
50,940
+12,140
+31% +$396K 0.02% 504
2014
Q4
$1.23M Buy
38,800
+15,000
+63% +$476K 0.01% 543
2014
Q3
$589K Hold
23,800
0.01% 582
2014
Q2
$538K Buy
+23,800
New +$538K 0.01% 707